Vicore Pharma AB’s Post

We're presenting three abstracts at #ARVO2024! The Exonate team will be presenting our exciting #clinicaltrial data from the recent Phase Ib/IIa mild NPDR/DME (NCT04565756) clinical study which assessed the safety, tolerability and signals of biological response to EXN407, as well as a digital strategy for #patient enrolment, and additional information on our lead candidate EXN407. More information below ⬇ #Ophthalmology #MacularEdema

Are you joining us at PSI 2024 next week? Make sure to stop by James Matcham's presentation "Advanced Trial Simulation in the Design of a Pivotal Cardiovascular Study: A Case Study" to discover how Cytel anticipates future developments both in the industry and across your therapeutic journey to ensure you always stay ahead of the curve! Can't make it? Stop by booth 18 any day and speak to our experts! Book a meeting here: https://hubs.ly/Q02B17jn0 #PSI #Biostatistics #HTA

Unlock insights from the #NeVa CLEAR Study! 🚀 Join Profs Serdar Geyik, Raul Nogueira, and Laurent SPELLE as they discuss the clinical outcomes with #Vesalio ’s NeVa™ #thrombectomy device in treating large vessel occlusion acute ischemic #stroke! Watch now 📽: https://ow.ly/jkal50QpUW0

Thus is cool because Such innovations will make Theranostics so such more accessible due to Lesser infrastructure requirements.

Our latest work is now appearing in JCI insight, where we describe the transcriptional profile of primary airway cells from subjects with PCD, and identify a unique expression profile in their cells compared to unaffected controls. We also identify a dedicated cilia expression of GSTA2. The video render shows the expression of GSTA2, a glutathione-s-transferase, within the airway cilia. Its levels is significantly increased in PCD patients. https://lnkd.in/exmyWpP8

got fusion?… Catamaran does! We're excited to invite you to a compelling Lunch Workshop at the upcoming ISASS meeting on April 27th in Miami, Florida. Drs. Scott Kutz and Matthew Davies, MD, FAANS, renowned experts in the field, will lead a dynamic session titled "Mastering the SI Joint: A Comprehensive Approach to Diagnosis, Intervention and New Fusion Evidence." Workshop Focus: - Advanced SI Joint Diagnosis: Gain insights into Dr. Kutz and Dr. Davies' proven approach to diagnosing SI joint issues. - Catamaran® System Innovation: Explore the groundbreaking features of the Catamaran system designed to achieve true arthrodesis/fusion of the SI joint. - Real-World Evidence from Post-Market Study: Drs. Kutz and Davies will present and analyze promising early fusion rate data observed with Catamaran in our ongoing clinical study. We encourage you to register for the workshop and join us for this informative session. To register, scan the QR code below or click here https://hubs.ly/Q02q-FQY0 #ISASS24 #sijointfusion #sijointdysfunction #catamaran #sijoint #TenonMedical #spine #transfixsacroiliacjoint #jibkit #fusion #arthodesis

Today kicks off #SNMMI24. Iomab-B and Actimab-A are the only targeted #radiotherapies in development for r/r #AML addressing different parts of the patient journey. We look forward to our presentations highlighting the Phase 3 SIERRA trial and Phase 1b trial of Actimab-A results. $ATNM

SDBN Feed: Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome https://lnkd.in/dkFtPGXk ION582 demonstrated consistent improvements across multiple functional domains in Angelman syndrome patients ION582 was safe and well tolerated at all dose levels Ionis plans to move ION582 into pivotal trial Detailed ION582 data to be [...]

The multi-national RESOLVE-AF trial enrolled its first patient in the EU today as Dr. Max Liebregts and Dr. Lucas Boersma completed the first case at St. Antonius Hospital Nieuwegein, The Netherlands. Boersma, the European PI for the international trial said, “I’m excited to participate in this study to evaluate Cortex’s EGF mapping as a promising approach to identify extra-pulmonary vein EGF sources and their phenotypes." RESOLVE-AF is a prospective, international, multi-center trial to evaluate the use of the OptiMap™ System and OptiMap™ Catheter to identify extra-pulmonary vein EGF sources and their phenotypes. #EPeeps, #AFablation

🚨 Missed the live Tweetorial by Dr Paolo Tarantino No worries! You can now watch the on-demand video here: https://lnkd.in/dBPp7QHf Join Dr Tarantino as he journeys through a ER+/HER2- #mBC patient case and explores the diagnostic and treatment processes including: 🔸When and how to use molecular testing to tailor treatment strategies 🔸2nd line treatment options for ER+ MBC 🔸The current data on oral SERDs as monotherapy and in combination therapy #MedEd #bcsm